Brief: Trans Lux Q4 EPS $0.14
March 21 (Reuters) - Trans Lux Corp TNLX.PK -
* Q4 earnings per share $0.14
* Q4 revenue $5.7 million versus $5.0 million
Source text for Eikon: ID:nPnYNM1xa
Further company coverage: TNLX.PK
((Bangalore.newsroom@thomsonreuters.com))
Recent news on Trans Lux
See all newsMorningstar sees margin expansion at Australia's Telix Pharmaceuticals, maintains revenue outlook
Australia's Telix Pharmaceuticals rises on China acceptance of new drug application
Australia's Telix Pharmaceuticals jumps after Jefferies hikes PT
Jefferies raises PT on Australia's Telix Pharmaceuticals on upbeat U.S. sales
Australia's Telix Pharma posts worst day in four months on discounted placement